Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · IEX Real-Time Price · USD
4.660
+0.410 (9.65%)
At close: May 17, 2024, 4:00 PM
4.690
+0.030 (0.64%)
After-hours: May 17, 2024, 7:58 PM EDT
Tenaya Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tenaya Therapeutics stock have an average target of 15, with a low estimate of 7.00 and a high estimate of 20. The average target predicts an increase of 221.89% from the current stock price of 4.66.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TNYA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +243.35% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +286.27% | May 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +329.18% | Mar 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +286.27% | Mar 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +286.27% | Mar 19, 2024 |
Financial Forecast
Revenue This Year
728.58K
Revenue Next Year
3.91M
from 728.58K
Increased by 436.66%
EPS This Year
-1.77
from -1.68
EPS Next Year
-1.85
from -1.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.3M | 15.8M | 77.5M | 544.6M | 1.7B |
| Avg | 728,576 | 3.9M | 41.7M | 285.5M | 828.4M |
| Low | n/a | n/a | n/a | 89.4M | 211.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 2,061.8% | 1,883.0% | 1,207.2% | 492.3% |
| Avg | - | 436.7% | 965.6% | 585.3% | 190.1% |
| Low | - | - | - | 114.5% | -25.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.54 | -1.43 | -0.79 | 2.43 | 11.98 |
| Avg | -1.77 | -1.85 | -1.74 | 0.57 | 4.82 |
| Low | -1.87 | -2.21 | -2.76 | -1.38 | -1.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,997.4% |
| Avg | - | - | - | - | 743.4% |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.